Metropolitan Digital

Google


.

What the FDA's accelerated approval of a new Alzheimer's drug could mean for those with the disease – 5 questions answered about lecanemab

  • Written by James E. Galvin, Professor of Neurology, University of Miami
What the FDA's accelerated approval of a new Alzheimer's drug could mean for those with the disease – 5 questions answered about lecanemabAlzheimer's disease is an incapacitating, progressive brain disorder that affects the lives of more than 6.5 million Americans. PamelaJoeMcFarlane/E+ via Getty Images

The U.S. Food and Drug Administration approved the medication lecanemab, sold under the brand name Leqembi, on Jan. 6, 2023, through an “accelerated approval pathway” that...

Read more: What the FDA's accelerated approval of a new Alzheimer's drug could mean for those with the...

More Articles ...

  1. What does ESG mean? Two business scholars explain what environmental, social and governance standards and principles are
  2. Native eastern fence lizards changed their bodies and behavior in response to invasive red imported fire ants
  3. Bringing manufacturing back to the US requires political will, but success hinges on training American workers
  4. Sitting all day is terrible for your health – now, a new study finds a relatively easy way to counteract it
  5. Inflation report is a mixed bag – an economist explains why some items are rising faster than others
  6. How the distortion of Martin Luther King Jr.'s words enables more, not less, racial division within American society
  7. What is the FAA's NOTAM? An aviation expert explains how the critical safety system works
  8. Reunions can be nostalgic and painful as well as happy – as the ancient Greek heroes Achilles and Odysseus show us
  9. US birth rates are at record lows – even though the number of kids most Americans say they want has held steady
  10. Meditation and mindfulness offer an abundance of health benefits and may be as effective as medication for treating certain conditions